Abstracts tagged "Anti-TNF therapy and health care cost"

Abstract Number: 2228 • ACR/ARHP Annual Meeting 2016
Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
A Nadkarni¹ and M Brouillette², ¹Bristol-Myers Squibb, Princeton, NJ, ²Truven Health Analytics, Bethesda, MD
Background/Purpose: RA patients (pts) receiving anti-TNF therapy may have an inadequate response (IR) to 1st-line treatment. Among pts for whom treatment fails, little is known…